Hainan Huluwa Pharmaceutical Group (605199.SH): Omeprazole enteric-coated capsules pass the consistency evaluation of generic drugs.

Hainan Huluwa Pharmaceutical Group (605199.SH) announced that the company recently received the approval notice for the supplementary application of the approval for omeprazole enteric-coated capsules ("the drug") issued by the National Medical Products Administration. The drug has passed the evaluation of generic drug quality and efficacy consistency. It is reported that omeprazole enteric-coated capsules have been included in the National Essential Medicines List, national medical insurance list, and provincial medical insurance list, suitable for the treatment of gastric ulcers, duodenal ulcers, gastroesophageal reflux disease, and Zollinger-Ellison syndrome (gastrinoma).